KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Income towards Parent Company: 2010-2025

Historic Income towards Parent Company for Pacira BioSciences (PCRX) over the last 16 years, with Sep 2025 value amounting to $5.4 million.

  • Pacira BioSciences' Income towards Parent Company rose 103.79% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.4 million, marking a year-over-year increase of 123.63%. This contributed to the annual value of -$99.6 million for FY2024, which is 337.30% down from last year.
  • Per Pacira BioSciences' latest filing, its Income towards Parent Company stood at $5.4 million for Q3 2025, which was up 212.07% from -$4.8 million recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Income towards Parent Company registered a high of $25.8 million during Q2 2023, and its lowest value of -$143.5 million during Q3 2024.
  • Its 3-year average for Income towards Parent Company is -$4.7 million, with a median of $9.0 million in 2024.
  • As far as peak fluctuations go, Pacira BioSciences' Income towards Parent Company spiked by 1,666.81% in 2023, and later slumped by 1,421.29% in 2024.
  • Pacira BioSciences' Income towards Parent Company (Quarterly) stood at -$5.1 million in 2021, then slumped by 96.92% to -$10.1 million in 2022, then spiked by 346.19% to $24.9 million in 2023, then plummeted by 35.50% to $16.0 million in 2024, then surged by 103.79% to $5.4 million in 2025.
  • Its Income towards Parent Company was $5.4 million in Q3 2025, compared to -$4.8 million in Q2 2025 and $4.8 million in Q1 2025.